Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was founded in 2005 and is headquartered in Raleigh, North Carolina.
IPO Year: 2019
Exchange: NYSE
Website: phreesia.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2025 | $26.00 | Overweight | Barclays |
| 11/13/2025 | $32.00 | Outperform | BMO Capital Markets |
| 9/5/2025 | $33.00 | Buy | DA Davidson |
| 8/27/2025 | $36.00 | Outperform | Mizuho |
| 1/8/2025 | $24.00 → $32.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/26/2024 | $35.00 | Buy | Truist |
| 1/17/2024 | $30.00 → $32.00 | Neutral → Buy | DA Davidson |
| 1/3/2024 | $29.00 | Overweight | Barclays |
| 4/12/2023 | $37.00 | Overweight | Stephens |
| 1/4/2023 | $35.00 → $40.00 | Buy | Needham |
Fastest customizable press release news feed in the world
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. "I am very proud of our team's strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal 2026 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2025 Highlights1 Total revenue was $120.3 million in the quarter, up 13% year-over-year. Average number of healthcare services clients ("AHSCs") was
Phreesia today announced that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M's 2025 40 Under 40 list. MM+M's annual 40 Under 40 list celebrates standout talent across healthcare marketing and communications. This year's honorees were chosen for their impact in shaping the future of medical marketing through creativity, leadership and a commitment to a more inclusive, patient-centered industry. "Megan has this rare ability to make operational excellence feel energizing," said Danielle Lynch, Vice President of Client Experience at Phreesia. "She brings empathy, creativity and a whole lot of fun to the work—and that combination has been trul
Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Deloitte Technology Fast 500™. Now in its 31st year, the prestigious list ranks the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America. "We're proud to be named to the Deloitte Fast 500 for the first time," said Phreesia CEO Chaim Indig. "This achievement is a testament to our team's hard work, creativity and commitment to our mission of making care easier every day. Phreesia's growth reflects our dedication to delivering value to healthcare organizations and their patients, and it's exciting to see that recognized." "This ye
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit t
Phreesia, a leader in patient intake, outreach and activation, has been named to the 2025 Capterra Shortlists in the Appointment Reminder and Appointment Scheduling categories. The Capterra Shortlist is an independent assessment that evaluates user reviews and online search activity to identify a list of market leaders that offer the top products in various software categories. "It's exciting to be named to the 2025 Capterra Shortlists for Appointment Reminders and Scheduling," said Phreesia CEO Chaim Indig. "Our digital tools help simplify scheduling for healthcare providers so they can boost engagement, reduce no-shows and accelerate patient care." These are the third and fourth Capte
Phreesia, a leader in patient intake, outreach and activation, has been named to TIME's list of the World's Top HealthTech Companies of 2025. The list, developed in partnership with Statista, highlights health tech companies that drive innovation, enhance accessibility, and contribute to a more effective and sustainable healthcare ecosystem. "Digital health's primary benefit will be in empowering patients to both learn more about their health, and also to take action to either avoid or manage conditions better," TIME said in its announcement of the inaugural list. Organizations were ranked based on financial performance, reputation analysis and online engagement, and categorized into si
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sara DiNardo, Vice President of Client Solutions, has been named in Becker's Hospital Review's 2025 list of Rising Stars: 100 Healthcare Leaders Under 40. "A new generation of bold, innovative healthcare leaders is making healthcare more accessible, affordable and seamless for patients everywhere," Becker's said in its announcement of the list. "With their drive, creativity and forward-thinking vision, they're poised to make a lasting impact within their institutions and across the healthcare landscape as a whole." In her role, Sara oversees Phreesia's client-facing teams to ensure its technology dr
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables. Please refer to the AccessOne press release published earlier today for addition
Phreesia, Inc. (NYSE:PHR) ("Phreesia"), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, "AccessOne"), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the "AccessOne Acquisition"). The transaction is expected to close during the third quarter or early fourth quarter of Phreesia's 2026 fiscal year, subject to customary closing conditions and regulatory approvals. AccessOne is a market leader in providing financing solutions for healthcare receivables, working with some of the largest health systems in the U.S. AccessOne t
New offering enhances Phreesia's existing platform, eliminating long hold times and ensuring every patient call is resolved Phreesia, a leader in patient activation, today announced the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare. VoiceAI leverages advanced natural language processing and real-time workflow integration to help healthcare organizations manage high call volumes, streamline routine interactions and improve the patient experience—all without increasing staff workload. VoiceAI allows patients to easily resolve common requests by using patients' natural spoken language. VoiceAI then triages and routes those patient requ
8-K - Phreesia, Inc. (0001412408) (Filer)
SCHEDULE 13G/A - Phreesia, Inc. (0001412408) (Subject)
SCHEDULE 13G/A - Phreesia, Inc. (0001412408) (Subject)
8-K - Phreesia, Inc. (0001412408) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
4 - Phreesia, Inc. (0001412408) (Issuer)
Barclays initiated coverage of Phreesia with a rating of Overweight and set a new price target of $26.00
BMO Capital Markets initiated coverage of Phreesia with a rating of Outperform and set a new price target of $32.00
DA Davidson resumed coverage of Phreesia with a rating of Buy and set a new price target of $33.00
Mizuho initiated coverage of Phreesia with a rating of Outperform and set a new price target of $36.00
RBC Capital Mkts upgraded Phreesia from Sector Perform to Outperform and set a new price target of $32.00 from $24.00 previously
Truist initiated coverage of Phreesia with a rating of Buy and set a new price target of $35.00
DA Davidson upgraded Phreesia from Neutral to Buy and set a new price target of $32.00 from $30.00 previously
Barclays initiated coverage of Phreesia with a rating of Overweight and set a new price target of $29.00
Stephens initiated coverage of Phreesia with a rating of Overweight and set a new price target of $37.00
Needham reiterated coverage of Phreesia with a rating of Buy and set a new price target of $40.00 from $35.00 previously
Live Leadership Updates
Phreesia will work with the NAI to shape the national conversation around data privacy and promote consumer choice and transparency As part of the company's ongoing commitment to consumer data privacy, Phreesia is pleased to announce it has joined the Network Advertising Initiative (NAI), a non–profit organization and the leading self-regulatory association dedicated to responsible data collection and use for digital advertising. As a member, Phreesia will work with the NAI to promote consumer-centric privacy practices in healthcare and take a leadership role in shaping the national conversation around data privacy. "We are excited to join the NAI, an organization that shares our dedicati
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Women Leaders in SaaS of 2023. Honorees were chosen based on their leadership and contributions to the Software-as-a-Service industry. This is the sixth consecutive year a female leader from Phreesia has been named to the list. Previous Phreesia awardees include Allison Hoffman, General Counsel; Kristin Roberts, Vice President of Product Management; Kharen Hauck, Vice President of Marketing; Amy VanDuyn, Senior Vice President of Human Resources; and Sara DiNardo, Vice President of Client Solutio
Live finance-specific insights
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. "I am very proud of our team's strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal 2026 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2025 Highlights1 Total revenue was $120.3 million in the quarter, up 13% year-over-year. Average number of healthcare services clients ("AHSCs") was
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2026 financial results after the close of market trading on Monday, Dec. 8, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit t
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. "I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables. Please refer to the AccessOne press release published earlier today for addition
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2026 financial results after the close of market trading on Thursday, Sept. 4, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or vi
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2025. "Our fiscal year 2026 is off to a strong start. I am grateful to our team for their continued commitment to our mission, vision and values. I believe our performance is a reflection of our team truly living our values," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q1 Fiscal 2026 Stakeholder Letter. Fiscal First Quarter Ended April 30, 2025 Highlights Total revenue was $115.9 million in the quarter, up 15% year-over-year. Average number of healthcare servi
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of market trading on Wednesday, May 28, 2025. Phreesia previously announced that it would release the results after the close of market trading on the same day. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 8:30AM Eastern Time on the same day. To participate in the company's live conference call and webcast,
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025. Phreesia will issue a press release announcing its quarterly results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal first quarter results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025. "We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience," said CEO and Co-Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q4 Fiscal 2025 Stakeholder Letter. Fiscal Fourth Quarter Ended January 31, 2025 Highlights Total revenue was $109.7 million in the quarter, up 15% year-over-year. Average num
Phreesia, Inc. (NYSE:PHR) ("Phreesia") today announced that it will release its fiscal fourth quarter and fiscal year 2025 financial results after the close of market trading on Wednesday, March 12, 2025. Phreesia will issue a press release announcing its quarterly and full year results and the company's quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal fourth quarter and fiscal year 2025 results starting at 5PM Eastern Time on the same day. To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international part
Phreesia, Inc. (NYSE:PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia," said CEO and Co-Founder Chaim Indig. "Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in." Please visit the Phreesia investor relations website at ir.phreesia.com to view the Company's Q3 Fiscal Year 2025 Stakeholder Letter. Fiscal Third Quarter Ended October 31, 2024 Highlights Total revenue was $106.8 million in the quarter, up 17% year-over-year. Average number of healthcare servi
This live feed shows all institutional transactions in real time.
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)
SC 13G/A - Phreesia, Inc. (0001412408) (Subject)